Home Microsoft AI National Initiative: Empowering Healthcare with Artificial Intelligence

Microsoft AI National Initiative: Empowering Healthcare with Artificial Intelligence

Oct 28, 2021 19:21 CST Updated 19:21


Global Power, Reshaping the Future

The Global Spotlight on2021 Pharmaceutical Digital Transformation Forum

Concluded successfully in Shanghai on October 21–22

How the Pharmaceutical Industry Moves from Visionary Aspirations to Practical Implementation

Find Answers Here


Gathering of Experts: Discussing the Digital Transformation of the Pharmaceutical Industry


The surging waves of emerging technologies such as 5G, AI, and the Industrial Internet+ are driving continuous change and innovation. Coupled with ongoing national policy reforms—including the Two-Invoice System, volume-based procurement, and increasingly stringent compliance requirements—digital transformation has become an inevitable trend for pharmaceutical companies. How to formulate a transformation roadmap, leverage digital technologies to enhance corporate competitiveness, and thereby drive profound restructuring of business operations, management, and commercial models across the industry has become an urgent challenge that pharmaceutical enterprises must address.


The 2021 Pharmaceutical Digital Transformation Forum, themed “Global Power, Digitally Transforming the Future,” invitedMore than 250CEOs, CIOs, CDOs, and other digital leaders from pharmaceutical companies, along with representatives from digital technology firms and strategic consulting experts, jointlyExploring How Digital Technology Empowers Pharmaceutical Companies’ Operations and Drives Innovation

 

Microsoft's National AI Initiative: Building a Healthcare Ecosystem


The development of pharmaceutical enterprises is vital to national welfare and the people’s livelihood; as the nation prospers, businesses bear corresponding responsibilities. As a trusted global digital enablement partner in China, Microsoft has been committed to helping healthcare clients deepen industry value and accelerate their digital transformation.


At this conference,Cui Xianghui, Microsoft Global Black Belt Technical ExpertBringMicrosoft's National AI Initiative Empowers Industrial TransformationAn analysis of innovative strategies, key technologies, and successful case studies to help pharmaceutical companies enhance their digital and intelligent capabilities, provide diverse perspectives for future digital transformation, and promote sustainable development.


1.png


 

Platform and Technology Synergy: Empowering the Pharmaceutical and Healthcare Industry


As a participant in and witness to the digital transformation of healthcare, Microsoft has been empowering innovation and progress in the pharmaceutical and health industries through its digital platforms. Microsoft established “Digital Alliance for the Healthcare Ecosystem", assuming the role of a super digital connector in the pharmaceutical industry, integrating upstream and downstream ecosystem partners—including government, pharmaceutical and medical device companies, distributors, healthcare institutions, retail pharmacies, and patients—throughSeries of Forums, IPS Competition, “Digital Intelligence in Medicine”, Ecosystem PartnersFour Key Initiatives: Empowering Pharmaceutical Companies to Unify Marketing Channels Through Platform Enablement, Accelerating Localization for Medical Device Enterprises, Facilitating Global Expansion for CRO and Biotech Firms, and Driving Cross-Border Collaborative Innovation from a Patient-Centric Perspective.


2.png 

 

Meanwhile, Microsoft is also continuously innovating AI technology to buildAzure HPC End-to-End Solution: Empowering AI-Driven New Drug DiscoveryAzure HPC is a high-performance computing platform with outstanding comprehensive capabilities across multiple dimensions, including accelerated computing performance, MPI parallelism, data bandwidth, storage performance, and service ecosystem. It supports hybrid cloud models, diverse resources, and a rich array of applications, offering massive elastic scalability in the cloud to help pharmaceutical companies enhance drug R&D efficiency through artificial intelligence technologies.


3.png 

 

Successful Customer Practices: Rebuilding Digital Competitiveness


Leveraging Microsoft’s intelligent cloud platform and AI solutions, numerous pharmaceutical companies have rapidly shifted gears amid the wave of digital transformation, rebuilding their digital capabilities and core competitiveness.


4.png


As a technology platform and services company, Microsoft remains committed to empowering the digital transformation of the pharmaceutical and healthcare industry. Adhering to the principles of leveraging digital technologies to empower patients and the public, accelerating innovation in medical research and development, safeguarding healthcare information security, optimizing the experience of healthcare professionals, and establishing agile operational processes, Microsoft continuously innovates in digital and intelligent technologies. This approach enhances enterprises’ digital capabilities and accelerates their transformation and innovation.